Stock Screener App

Gratuito -

Installare

6.10

0.00% 0.00

Atea Pharmaceuticals Inc (AVIR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Atea Pharmaceuticals Inc Azioni (AVIR) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	20.56% 54.93	45.57	41.34	39.04	39.03
Depreciation and Amortization	0.00% 0.104	0.104	0.104	0.104	0.104
Operating Income/Loss	20.56% -54.93	-45.57	-41.34	-39.04	-39.03
Income/Loss From Continuing Operations Before Tax	23.37% -51.63	-41.85	-36.95	-34.07	-33.32
Income Tax Expense/Benefit	3,553% -6.768	0.196	0.207	0.203	0.225
Income/Loss From Continuing Operations After Tax	6.70% -44.87	-42.05	-37.16	-34.27	-33.54
Net Income/Loss	6.70% -44.87	-42.05	-37.16	-34.27	-33.54
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	101.43% -1.1285	79.05	83.75	85.16	0.0666
Diluted Average Shares	101.43% -1.1285	79.05	83.75	85.16	0.0666
Basic Earnings Per Share	7.55% -0.57	-0.53	-0.44	-0.40	-0.40
Diluted Earnings Per Share	7.55% -0.57	-0.53	-0.44	-0.40	-0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters